Mrs. Spelman: To ask the Secretary of State for Health how much public money has been spent on the AD2000 study of the effectivenessof donepezil in each of the years (a) 1998, (b) 1999, (c) 2000 and (d) 2001, broken down by (i) the amount spent by individualhealth authorities on the trial, (ii) the amount allocated to the trial from regional research and development budgets, (iii) theamount allocated from the national research and development extra treatment costs fund and (iv) other NHS costs incurred as a resultof the trial. [154072]Ms Stuart: [holding answer 16 March 2001]: The information is not available in the format requested.The Department has been sponsoring a trial on the long-term effectiveness of donepezil (ARICEPT). The table shows expenditure fromthe west midlands regional office of the national health service executive and the excess treatment costs budget for this trial.£_________________________________________________________________________________________________.West midlands regional office Excess treatment costs1997-98 5,000 --1998-99 122,412 --1999-2000 245,870 --2000-01 225,723 145,0002001-02 224,973 {1}200,000_________________________________________________________________________________________________.{1} Estimate